Retrospective Evaluation of Liposarcoma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03034252

Acronym

RELiSa

Enrollment

100

Registered

2017-01-27

Start date

2016-01-31

Completion date

2017-01-31

Last updated

2017-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Survival , Tumor

Brief summary

Retrospective Evaluation of Survival after Liposarcoma

Interventions

PROCEDUREPatients with Liposarcoma

Evaluation of Liposarcoma treated in a single center

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Inclusion criteria

* Patients with Liposarcoma treated surgically at our clinic

Exclusion criteria

* N/A

Design outcomes

Primary

Measure	Time frame
Survival rate	2 years

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026